Literature DB >> 27920637

Endocrinological Abnormalities Are a Main Feature of 17p13.1 Microduplication Syndrome: A New Case and Literature Review.

Ilenia Maini1, Ivan Ivanovski2, Alessandro Iodice3, Simonetta Rosato4, Marzia Pollazzon4, Manuela Mussini4, Elga F Belligni5, Charles Coutton6, Maria Marinelli7, Veronica Barbieri7, Manuela Napoli8, Rosario Pascarella8, Chiara Sartori9, Francesca Madia10, Carlo Fusco7, Fabrizia Franchi7, Maria E Street9, Livia Garavelli4.   

Abstract

To date, 5 cases of 17p13.1 microduplications have been described in the literature. Intellectual disability was reported as the core feature, together with minor facial dysmorphisms and obesity, but a characteristic phenotype for 17p13.1 microduplication has not been delineated. Here, we describe a patient with a 1.56-Mb de novo duplication in 17p13.1, affected by mild intellectual disability, facial dysmorphisms, obesity, and diabetes. By comparing the different phenotypes of currently described cases, we delineated the main clinical features of 17p13.1 microduplication syndrome. All patients described to date had variable facial dysmorphisms; therefore, it was difficult to define a common facial gestalt. Furthermore, we stress endocrinological abnormalities as important features and the need to monitor these over time.

Entities:  

Keywords:  Diabetes; Endocrine disorders; Intellectual disability; Microduplication syndrome 17p13.1; Obesity

Year:  2016        PMID: 27920637      PMCID: PMC5131335          DOI: 10.1159/000450718

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  10 in total

1.  Dosage changes of a segment at 17p13.1 lead to intellectual disability and microcephaly as a result of complex genetic interaction of multiple genes.

Authors:  Claudia M B Carvalho; Shivakumar Vasanth; Marwan Shinawi; Chad Russell; Melissa B Ramocki; Chester W Brown; Jesper Graakjaer; Anne-Bine Skytte; Angela M Vianna-Morgante; Ana C V Krepischi; Gayle S Patel; LaDonna Immken; Kyrieckos Aleck; Cynthia Lim; Sau Wai Cheung; Carla Rosenberg; Nicholas Katsanis; James R Lupski
Journal:  Am J Hum Genet       Date:  2014-11-06       Impact factor: 11.025

2.  Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children.

Authors:  Gabriel I Uwaifo; Erica M Fallon; Jeff Chin; Jane Elberg; Shamik J Parikh; Jack A Yanovski
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

3.  790 Kb microduplication in chromosome band 17p13.1 associated with intellectual disability, afebrile seizures, dysmorphic features, diabetes, and hypothyroidism.

Authors:  Elga Fabia Belligni; Eleonora Di Gregorio; Elisa Biamino; Alessandro Calcia; Cristina Molinatto; Flavia Talarico; Giovanni Battista Ferrero; Alfredo Brusco; Margherita Cirillo Silengo
Journal:  Eur J Med Genet       Date:  2012-02-06       Impact factor: 2.708

4.  17p13.1 microduplication in a boy with Silver-Russell syndrome features and intellectual disability.

Authors:  Charles Coutton; Francoise Devillard; Gaëlle Vieville; Florence Amblard; Gipsy Lopez; Pierre-Simon Jouk; Véronique Satre
Journal:  Am J Med Genet A       Date:  2012-08-17       Impact factor: 2.802

5.  Neurodevelopmental delays and macrocephaly in 17p13.1 microduplication syndrome.

Authors:  Kathryn Anne Mooneyham; Kenton R Holden; Sara Cathey; Alka Dwivedi; Barbara R Dupont; Michael J Lyons
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

6.  A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish.

Authors:  Yuta Komoike; Keiko Shimojima; Jao-Shwann Liang; Hiroshi Fujii; Yoshihiro Maegaki; Makiko Osawa; Sakiko Fujii; Toru Higashinakagawa; Toshiyuki Yamamoto
Journal:  J Hum Genet       Date:  2010-01-29       Impact factor: 3.172

7.  Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1.

Authors:  A C V Krepischi-Santos; D Rajan; I K Temple; V Shrubb; J A Crolla; S Huang; S Beal; P A Otto; N P Carter; A M Vianna-Morgante; C Rosenberg
Journal:  Cytogenet Genome Res       Date:  2009-07-14       Impact factor: 1.636

8.  De novo duplication of 17p13.1-p13.2 in a patient with intellectual disability and obesity.

Authors:  Yukiko Kuroda; Ikuko Ohashi; Makiko Tominaga; Toshiyuki Saito; Jun-Ichi Nagai; Kazumi Ida; Takuya Naruto; Mitsuo Masuno; Kenji Kurosawa
Journal:  Am J Med Genet A       Date:  2014-03-25       Impact factor: 2.802

9.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06

10.  Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice.

Authors:  Seok Kim; Jaehoon Jung; Hwajin Kim; Rok Won Heo; Chin-Ok Yi; Jung Eun Lee; Byeong Tak Jeon; Won-Ho Kim; Jong Ryeal Hahm; Gu Seob Roh
Journal:  Korean J Physiol Pharmacol       Date:  2014-08-13       Impact factor: 2.016

  10 in total
  1 in total

1.  Absence of RNA-binding protein FXR2P prevents prolonged phase of kainate-induced seizures.

Authors:  Adrian C Lo; Nicholas Rajan; Denise Gastaldo; Ludovic Telley; Muna L Hilal; Andrea Buzzi; Michele Simonato; Tilmann Achsel; Claudia Bagni
Journal:  EMBO Rep       Date:  2021-03-28       Impact factor: 8.807

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.